ClearPoint Neuro, Inc. – NASDAQ:CLPT
ClearPoint Neuro stock price today
$10.5
-5.25
-33.33%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 8 hours
ClearPoint Neuro stock price monthly change
+109.44%
month
ClearPoint Neuro stock price quarterly change
+109.44%
quarter
ClearPoint Neuro stock price yearly change
+126.94%
year
ClearPoint Neuro key metrics
Market Cap | 409.91M |
Enterprise value | 211.92M |
P/E | -13.07 |
EV/Sales | 10.31 |
EV/EBITDA | -13.66 |
Price/Sales | 11.07 |
Price/Book | 6.16 |
PEG ratio | -9.01 |
EPS | -0.84 |
Revenue | 26.16M |
EBITDA | -19.72M |
Income | -20.62M |
Revenue Q/Q | 40.60% |
Revenue Y/Y | 24.85% |
Profit margin | -79.97% |
Oper. margin | -79.47% |
Gross margin | 65.84% |
EBIT margin | -79.47% |
EBITDA margin | -75.41% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeClearPoint Neuro stock price history
ClearPoint Neuro stock forecast
ClearPoint Neuro financial statements
| Jun 2023 | 5.95M | -7.05M | -118.52% |
|---|---|---|---|
| Sep 2023 | 5.76M | -4.80M | -83.46% |
| Dec 2023 | 6.81M | -4.61M | -67.83% |
| Mar 2024 | 7.63M | -4.14M | -54.27% |
| 2025 | 42.21M | -16.51M | -39.12% |
|---|---|---|---|
| 2026 | 58.3M | -15.1M | -25.9% |
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 47641000 | 20.23M | 42.47% |
|---|---|---|---|
| Sep 2023 | 43837000 | 19.74M | 45.04% |
| Dec 2023 | 42661000 | 21.48M | 50.37% |
| Mar 2024 | 53637000 | 19.05M | 35.52% |
| Jun 2023 | -5.07M | 9.51M | 237K |
|---|---|---|---|
| Sep 2023 | -1.79M | -235K | -91K |
| Dec 2023 | -1.16M | -188K | 155K |
| Mar 2024 | -3.84M | 0 | 16.05M |
ClearPoint Neuro alternative data
ClearPoint Neuro Social Media Accounts
What are followers?
| May 2025 | 206 |
|---|---|
| Jul 2025 | 212 |
| Aug 2025 | 212 |
ClearPoint
| 11 Jun 2023 | 72 |
|---|---|
| 18 Jun 2023 | 88 |
| 25 Jun 2023 | 55 |
| 2 Jul 2023 | 56 |
| 9 Jul 2023 | 57 |
| 16 Jul 2023 | 54 |
| 23 Jul 2023 | 55 |
| 30 Jul 2023 | 71 |
| 6 Aug 2023 | 63 |
| 13 Aug 2023 | 69 |
| 20 Aug 2023 | 67 |
| 27 Aug 2023 | 44 |
| 3 Sep 2023 | 47 |
| 10 Sep 2023 | 67 |
| 17 Sep 2023 | 51 |
| 24 Sep 2023 | 48 |
| 1 Oct 2023 | 24 |
| 8 Oct 2023 | 65 |
| 15 Oct 2023 | 37 |
| 22 Oct 2023 | 46 |
Neurosurgery
| 5 Feb 2023 | 89 |
|---|---|
| 12 Feb 2023 | 91 |
| 19 Feb 2023 | 83 |
| 26 Feb 2023 | 86 |
| 5 Mar 2023 | 85 |
| 12 Mar 2023 | 84 |
| 19 Mar 2023 | 84 |
| 26 Mar 2023 | 82 |
| 2 Apr 2023 | 75 |
| 9 Apr 2023 | 85 |
| 16 Apr 2023 | 78 |
| 23 Apr 2023 | 70 |
| 30 Apr 2023 | 75 |
| 7 May 2023 | 83 |
| 14 May 2023 | 63 |
| 21 May 2023 | 78 |
| 28 May 2023 | 80 |
| 4 Jun 2023 | 78 |
| 11 Jun 2023 | 62 |
| 18 Jun 2023 | 67 |
Numbers represent search interest relative to the highest point on the chart for the given region and time.
A value of 100 is the peak popularity for the term.
A value of 50 means that the term is half as popular.
A score of 0 means there was not enough data for this term.
| Sep 2023 | 108 |
|---|---|
| Oct 2023 | 108 |
| Nov 2023 | 108 |
| Dec 2023 | 108 |
| Jan 2024 | 108 |
| Feb 2024 | 108 |
| Mar 2024 | 107 |
| Apr 2024 | 107 |
| May 2024 | 107 |
| Jun 2024 | 107 |
| Jul 2024 | 107 |
ClearPoint Neuro other data
8.56%
-8.46%
of CLPT is owned by hedge funds
32
-28
2.06M
-2.09M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Sep 2021 | 0 | 9637 |
| Nov 2021 | 0 | 10000 |
| Aug 2022 | 0 | 18867 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Option | FALLON LYNNETTE C director | Common Stock | 17,153 | N/A | N/A | ||
Option | FALLON LYNNETTE C director | Restricted Stock Units | 17,153 | N/A | N/A | ||
Option | FLETCHER R JOHN director | Common Stock | 17,153 | N/A | N/A | ||
Option | FLETCHER R JOHN director | Restricted Stock Units | 17,153 | N/A | N/A | ||
Option | GIRIN PASCAL E R director | Common Stock | 17,153 | N/A | N/A | ||
Option | LIAU LINDA M. director | Common Stock | 17,153 | N/A | N/A | ||
Option | LIAU LINDA M. director | Restricted Stock Units | 17,153 | N/A | N/A | ||
Option | RICHARDS TIMOTHY T. director | Common Stock | 17,153 | N/A | N/A | ||
Option | RICHARDS TIMOTHY T. director | Restricted Stock Units | 17,153 | N/A | N/A | ||
Option | GIRIN PASCAL E R director | Restricted Stock Units | 17,153 | N/A | N/A |
| Patent |
|---|
Application SURGICAL BASE ASSEMBLIES FOR TRAJECTORY GUIDE SYSTEMS AND ASSOCIATED TRAJECTORY GUIDE SYSTEMS AND METHODS Filling date: 30 Sep 2021 Issue date: 16 Jun 2022 |
Grant Filling date: 27 Jun 2019 Issue date: 22 Feb 2022 |
Grant Filling date: 12 Dec 2018 Issue date: 22 Feb 2022 |
Application SURGICAL PLANNING SYSTEMS THAT AUTOMATICALLY ASSESS DIFFERENT POTENTIAL TRAJECTORY PATHS AND IDENTIFY CANDIDATE TRAJECTORIES FOR SURGICAL SYSTEMS Filling date: 16 Apr 2021 Issue date: 4 Nov 2021 |
Application MRI SURGICAL SYSTEMS INCLUDING MRI-COMPATIBLE SURGICAL CANNULAS FOR TRANSFERRING A SUBSTANCE TO AND/OR FROM A PATIENT Filling date: 15 Sep 2020 Issue date: 14 Oct 2021 |
Application IMAGE-GUIDED SURGICAL SYSTEMS WITH AUTOMATED TRAJECTORY GUIDE SYSTEMS AND RELATED DEVICES AND METHODS Filling date: 25 Feb 2021 Issue date: 16 Sep 2021 |
Application Filling date: 30 Apr 2021 Issue date: 19 Aug 2021 |
Application SURGICAL TOOL SUPPORT SYSTEMS INCLUDING ELONGATE SUPPORT LEGS WITH ADJUSTABLE LENGTHS AND RELATED METHODS Filling date: 21 Jan 2021 Issue date: 5 Aug 2021 |
Application Filling date: 15 Jan 2021 Issue date: 22 Jul 2021 |
Application Filling date: 25 Sep 2020 Issue date: 24 Jun 2021 |
| Quarter | Transcript |
|---|---|
| Q1 2024 7 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 12 Mar 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 9 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 8 Aug 2023 | Q2 2023 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
| Mr. Joseph Michael Burnett (1977) Pres, Chief Executive Officer & Director | $596,510 |
| Mr. Peter G. Piferi (1959) Chief Operating Officer | $365,940 |
ClearPoint Neuro: Consumables Growth Is Promising
I Missed The Quantum Rally - I Won't Miss The Next One
ClearPoint Neuro: Fundamentals Continue To Strengthen
NeuroOne Medical Technologies: A Small-Cap Electrode Technology Play With Multiple Catalysts Ahead
ClearPoint Neuro: Solid Progress Still Not Reflected In The Share Price
ClearPoint Neuro: Macro-Induced Multiple Compression
NeuroOne: A Hidden Contender Against ClearPoint In The Brain Drug Delivery Arena
ClearPoint Neuro Continues To Make Progress
ClearPoint Neuro Is A 'Buy' Based On Growing Revenues And Decreasing Cash Burn
-
What's the price of ClearPoint Neuro stock today?
One share of ClearPoint Neuro stock can currently be purchased for approximately $10.5.
-
When is ClearPoint Neuro's next earnings date?
Unfortunately, ClearPoint Neuro's (CLPT) next earnings date is currently unknown.
-
Does ClearPoint Neuro pay dividends?
No, ClearPoint Neuro does not pay dividends.
-
How much money does ClearPoint Neuro make?
ClearPoint Neuro has a market capitalization of 409.91M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 16.56% to 23.96M US dollars.
-
What is ClearPoint Neuro's stock symbol?
ClearPoint Neuro, Inc. is traded on the NASDAQ under the ticker symbol "CLPT".
-
What is ClearPoint Neuro's primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of ClearPoint Neuro?
Shares of ClearPoint Neuro can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are ClearPoint Neuro's key executives?
ClearPoint Neuro's management team includes the following people:
- Mr. Joseph Michael Burnett Pres, Chief Executive Officer & Director(age: 48, pay: $596,510)
- Mr. Peter G. Piferi Chief Operating Officer(age: 66, pay: $365,940)
-
How many employees does ClearPoint Neuro have?
As Jul 2024, ClearPoint Neuro employs 107 workers.
-
When ClearPoint Neuro went public?
ClearPoint Neuro, Inc. is publicly traded company for more then 13 years since IPO on 22 May 2012.
-
What is ClearPoint Neuro's official website?
The official website for ClearPoint Neuro is clearpointneuro.com.
-
Where are ClearPoint Neuro's headquarters?
ClearPoint Neuro is headquartered at 120 S. Sierra Avenue, Solana Beach, CA.
-
How can i contact ClearPoint Neuro?
ClearPoint Neuro's mailing address is 120 S. Sierra Avenue, Solana Beach, CA and company can be reached via phone at +888 2879109.
ClearPoint Neuro company profile:
ClearPoint Neuro, Inc.
clearpointneuro.comExchange:
NASDAQ
Full time employees:
107
Industry:
Medical - Devices
Sector:
Healthcare
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain stimulation electrodes and biopsy needles, and the infusion of pharmaceuticals and laser catheters into the brain; and ClearPoint Neuro Navigation System, an MRI suite. It has license and collaboration agreements with Boston Scientific Corporation, The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N.V., Blackrock Neurotech, and University of California and San Francisco. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.
120 S. Sierra Avenue
Solana Beach, CA 92075
Solana Beach, CA 92075
CIK: 0001285550
ISIN: US18507C1036
CUSIP: 18507C103
